idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Is cardiac computed tomography (CT) as reliable as catheterization in patients with suspected coronary artery disease? Under the leadership of Charité – Universitätsmedizin Berlin, researchers from 31 European clinical institutions worked together to address this question as part of the DISCHARGE trial. The aim of the trial was to test cardiac CT as a non-invasive alternative to catheterization, the current standard diagnostic test for intermediate-risk patients. A comprehensive analysis of the study’s results, which has been published in the New England Journal of Medicine*, suggests that CT offers a similar level of diagnostic accuracy.
European consortium tests computed tomography as an alternative to cardiac catheterization
Coronary artery disease (CAD) is common across the globe and is one of the leading causes of death in developed countries and aging populations. The disease is associated with impaired blood flow in the coronary arteries, i.e., the arteries which supply oxygen to the heart. Chest pain, shortness of breath and fatigue with activity can all be indicators of either chronic or acute disease, both of which are associated with an increased risk of heart attack, stroke and even cardiovascular death – examples of what are referred to ‘major adverse cardiovascular events’. Symptoms of CAD are caused by deposits inside the artery walls which build up over many years.
The current standard diagnostic test for coronary artery disease is a minimally invasive procedure known as coronary angiography (or cardiac catheterization). This test shows if the coronary arteries supply a sufficient amount of blood or whether blood flow is impaired by arterial narrowing. Any narrowing detected in this manner can be treated during the procedure itself, through the use of small, inflatable balloons and extremely thin mesh tubes known as stents, which are used to prop open the newly widened blood vessels. More than 3.5 million of these procedures are carried out in European catheterization laboratories (or cath labs) every year, and numbers continue to increase. Approximately two million – i.e., significantly more than half – of these minimally invasive procedures do not involve immediate treatment in the cath lab. In these cases, the procedure is able to rule out narrowed or blocked coronary arteries.
The main question addressed by the DISCHARGE trial was whether the low-risk, non-invasive coronary CT method can provide a safe alternative to catheterization in certain patients with suspected CAD. In order to test the effectiveness of both of these diagnostic imaging techniques in patients with stable chest pain, the project followed more than 3,500 patients for a duration of four years. Using a process known as randomization, patients were assigned by chance to either computed tomography or cardiac catheterization. If their initial evaluation ruled out obstructive coronary artery disease, participants were discharged back to their referring physician for further treatment – a step which gave the trial its name: DISCHARGE. Patients who were diagnosed as having the disease were managed in accordance with European guidelines at the time of the study.
The trial was led by Prof. Dr. Marc Dewey, Vice Chair of the Department of Radiology on Campus Charité Mitte, and his team, and involved a total of 31 partner institutions from across 18 European countries. Discussing the study’s long-term results, Prof. Dewey says: “The trial confirmed that a CT-based management is safe in patients with stable (i.e., non-acute) chest pain and suspected coronary artery disease.” Evaluation of safety was based on the incidence of major cardiovascular events over a period of up to four years. “Among the patients referred for cardiac catheterization and included in this trial, the risk of major adverse cardiovascular events was found to be similar in both the CT and catheterization groups, occurring in 2.1% and 3.0% of patients, respectively. The incidence of major procedure-related complications was found to be four-times lower in patients managed with an initial CT strategy,” says the radiologist.
Prof. Dr. Henryk Dreger, Deputy Head of Charité’s Department of Cardiology and Angiology, was responsible for monitoring the catheterization lab procedures performed at Charité. He concludes: “CT may represent a safe alternative to cardiac catheterization in specific patients. In patients with a low risk of CAD diagnosis, CT can help prevent an unnecessary catheterization procedure.” For their overall analysis, the researchers also included criteria such as improvements in chest pain and quality of life over the course of the trial. By helping to reduce the large number of catheterization procedures being performed, this new strategy could also help relieve pressure on health care systems. Summing up the significance of the research, Prof. Dewey says: “Now that CT has been standardized and quality-tested as part of the DISCHARGE trial, this method could be made more widely available as part of the routine clinical care of people with intermediate CAD risk.” The Federal Joint Committee (G-BA) has initiated a formal assessment to evaluate the benefits of cardiac CT. As a next step, the trial’s method for estimating a person’s clinical risk of having coronary artery disease will need to be further evaluated to determine whether it can help to improve routine care.
About the European DISCHARGE project
DISCHARGE is a multinational research consortium comprising 31 members from 18 European countries. At the project’s core is a randomized, controlled trial which includes 26 clinical sites and has been running since 2015. Drawing on insights gained as part of the Charité-based CAD-Man study, the project investigates whether (and which) patients with stable chest pain and a suspected diagnosis of coronary artery disease may benefit from a diagnostic imaging strategy using computed tomography (CT) as opposed to catheterization. The DISCHARGE study was part-funded by the European Union’s Seventh Framework Program (Grant No. 603266 l ClinicalTrials.gov number NCT02400229) for a duration of 6 years (2014 to 2020).
Prof. Dr. Marc Dewey
Deputy Head, Department of Radiology
Campus Charité Mitte
Charité – Universitätsmedizin Berlin
Tel: +49 30 450 527 353
Email: marc.dewey@charite.de
*The DISCHARGE Trial Group. ‘CT or Invasive Coronary Angiography in Stable Chest Pain.’ NEJM. 2022 online 4 March 2022, https://www.nejm.org/doi/full/10.1056/NEJMoa2200963
https://www.nejm.org/doi/full/10.1056/NEJMoa2200963
https://radiologie.charite.de/en/
https://herz.charite.de/
https://www.dischargetrial.eu/
Merkmale dieser Pressemitteilung:
Journalisten, Wissenschaftler
Medizin
überregional
Forschungsergebnisse
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
